ProfileGDS4095 / 202123_s_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 78% 79% 79% 80% 79% 80% 80% 79% 79% 80% 79% 79% 78% 78% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep18.4697978
GSM709769LY2 SRC1-siRNA tamoxifen treated rep38.5822879
GSM709765LY2 SRC1-siRNA untreated rep38.6753979
GSM709771LY2 SRC1-siRNA untreated rep18.7064380
GSM709772LY2 SRC1-siRNA untreated rep28.6475279
GSM709775LY2 SRC1-siRNA untreated rep48.7102280
GSM709764LY2 control-siRNA tamoxifen treated rep28.8450480
GSM709766LY2 control-siRNA tamoxifen treated rep38.5804479
GSM709768LY2 control-siRNA tamoxifen treated rep18.6581279
GSM709777LY2 control-siRNA tamoxifen treated rep48.7348880
GSM709770LY2 control-siRNA untreated rep38.7049679
GSM709773LY2 control-siRNA untreated rep18.6047979
GSM709774LY2 control-siRNA untreated rep28.4673578
GSM709776LY2 control-siRNA untreated rep48.4447378